[DOI] [PMC free article] [PubMed] [Google Scholar] Iakovou E, Kourti M
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients With Type 2 Diabetes
This depletion may impact the body's ability to combat oxidative damage, making it essential to support optimal glutathione levels through diet, lifestyle choices, and high-quality supplementation
J.GustafssonJ
Rising Demand for Oral and Non-Injectable GLP-1 Formulations The rising demand for oral and non-injectable GLP-1 formulations creates immense opportunities in the market by improving patient convenience and adherence
Additionally, research to examine the newer and more potent weight-loss GLP-1 receptor agonists, semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Mounjaro/Zepbound, Eli Lilly), would be particularly important.